Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Directory
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Ligand Pharmaceuticals
Sort By
Newest First
1 / 1
Licensing
Cumulus Oncology Licenses Chk1 Kinase Inhibitor Candidate from Ligand
Emilie Branch
Pharma's Almanac
PAO-M05-19-NI-025
May 29, 2019
Acquisition
Ligand Makes Offer to Acquire Vernalis, a Leader in Structure-Based Drug Discovery, For Approximately $43 Million in Cash
Ligand Pharmaceuticals
PR-M08-18-NI-107
Aug 28, 2018
Investment
Ligand Receives $47 Million from WuXi Biologics for Expansion of Worldwide OmniAb® Platform License Agreement
Ligand Pharmaceuticals
PR-M06-18-NI-098
Jun 29, 2018
1 / 1
